Form 4 for TXG 10x Genomics, Inc.

Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-21 · accession 0001567619-21-022503 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2021-12-23	2021-12-21	TXG	CRUTCHFIELD BRADFORD	Chief Commercial Off	M - OptEx	$4.71	+54.6K	97.7K	+127%	+$257.2K
DM	2021-12-23	2021-12-21	TXG	CRUTCHFIELD BRADFORD	Chief Commercial Off	M - OptEx	$0.00	-54.6K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-12-21	M	A	4,688	$1.20	47,743	D	—	—
2	Common	Class A Common Stock	2021-12-21	M	A	49,910	$5.04	97,653	D	—	—
3	Derivative	Stock Option (right to buy)	2021-12-21	M	D	49,910	$0.00	61,757	D	$5.04 · — to 2028-11-02	49,910 Class A Common Stock	(F2) This option, originally for 125,000 shares, of which 63,243 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
4	Derivative	Stock Option (right to buy)	2021-12-21	M	D	4,688	$0.00	0	D	$1.20 · — to 2027-10-18	4,688 Class A Common Stock	(F1) This option, originally for 25,000 shares, of which 25,000 shares have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.